These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15255289)

  • 1. A combination therapy with copper nicotinate complex reduces the adverse effects of 5-fluorouracil on patients with hepatocellular carcinoma.
    El-Saadani MA
    J Exp Ther Oncol; 2004 Apr; 4(1):19-24. PubMed ID: 15255289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver.
    Salama RH; Nassar AY; Nafady AA; Mohamed HH
    Liver Int; 2007 May; 27(4):454-64. PubMed ID: 17403185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of fluorouracil-related genes by microdissection technique in hepatocellular carcinoma.
    Takahashi T; Yoshida H; Mamada Y; Taniai N; Mizuguchi Y; Shimizu T; Kakinuma D; Ishikawa Y; Akimaru K; Sugisaki Y; Tajiri T
    Hepatogastroenterology; 2007 Sep; 54(78):1612-6. PubMed ID: 18019677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of non-ceruloplasmin copper to oxidative stress in patients with hepatocellular carcinoma.
    Geetha A; Saranya P; Annie Jeyachristy S; Surendran R; Sundaram A
    Biol Trace Elem Res; 2009 Sep; 130(3):229-40. PubMed ID: 19229483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Marubashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Aozasa K; Monden M
    J Gastroenterol; 2004 Aug; 39(8):793-7. PubMed ID: 15338375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY; Uchida H; Iwaki K; Kai S; Shibata K; Ohta M; Kitano S
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):957-9. PubMed ID: 17565266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
    Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
    Yang L; Wu D; Luo K; Wu S; Wu P
    Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
    Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrahepatic arterial chemotherapy with 5-fluorouracil and intramuscular interferon-alpha for a patient with diffuse type of hepatocellular carcinoma].
    Ochiai T; Sonoyama T; Kikuchi S; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ueda Y; Otsuji E; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1815-8. PubMed ID: 15553725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [S-1 treatment against advanced HCC].
    Nakamura M; Nagano H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():230-5. PubMed ID: 16898008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.